<ѻý>Laparoscopy, Surgery in a Draw for Gastric Cancer Survivalѻý> Laparoscopy-assisted distal gastrectomy noninferior for both relapse-free, overall survival Mar 15, 2023
<ѻý>Take Risk Into Account Before Repeat Surveillance Colonoscopy, Study Saysѻý> 58% of seniors with limited life expectancy, no significant findings invited for another round Mar 14, 2023
<ѻý>Novel PET Imaging Agent Accurately IDs Clear Cell Renal Cancersѻý> ZIRCON trial meets sensitivity and specificity targets Mar 13, 2023
<ѻý>FDA Panel Endorses New First-Line Lymphoma Regimenѻý> POLARIX trial supports a favorable risk-benefit profile for polatuzumab vedotin, ODAC members say Mar 10, 2023
<ѻý>Focus on Optimizing Use of CDK4/6 Inhibitors in Metastatic HR+ Breast Cancerѻý> Choice of agent, post-progression treatment, and resistance mechanisms top unanswered questions Mar 08, 2023
<ѻý>Understanding of HER2-Low Breast Cancer Continues to Evolveѻý> New breast cancer subtype proves challenging to define molecularly, pathologically, clinically Mar 07, 2023
<ѻý>FDA Not Quite Sold on Polivy in Frontline Large B-Cell Lymphoma Regimenѻý> Ahead of ODAC meeting, agency reviewers suggest modest PFS results in POLARIX "raise uncertainty" Mar 07, 2023
<ѻý>A Space for Mysteryѻý> Elisha Waldman, MD, discusses faith and spirituality in medicine Mar 07, 2023 podcast
<ѻý>Full-Dose Anticoagulation Again Favored for COVID Admissionsѻý> Despite failures, FREEDOM trial supports mortality advantage in general ward use Mar 07, 2023
<ѻý>KRAS Mutations in Metastatic CRC Predict Survival Benefit of Chemo Comboѻý> Trifluridine/tipiracil fails to improve survival in patients with KRAS G12-mutant tumors Mar 06, 2023
<ѻý>Cases of Breast Implant-Associated Lymphoma Continue to Accumulateѻý> More than 1,300 cases and 35 deaths, as reports of other implant-linked malignancies emerge Mar 06, 2023
<ѻý>'Our Goal Is Not to Omit Radiation Therapy' in Breast Cancerѻý> Honing indications for de-escalation of treatment intensity and, yes, selective omission of RT Mar 06, 2023
<ѻý>Antibody-Drug Conjugates Take Breast Cancer Field by Stormѻý> Established role in metastatic disease, may eventually replace chemotherapy Mar 04, 2023
<ѻý>Atorvastatin Tied to Cardioprotection for Lymphoma Patients on Anthracyclinesѻý> STOP-CA deemed "an impactful study that will lead to more prescription of statins in patients." Mar 04, 2023
<ѻý>These Surgeries Made the Sharpest Turns to Outpatient Setting After COVIDѻý> Several procedures saw significant increases in outpatient volumes Mar 03, 2023
<ѻý>'Winners' and 'Losers'; Mandated Sick Leave and Cancer Screening; More AI Advancesѻý> News, features, and commentary about cancer-related issues Mar 03, 2023
<ѻý>Cancer-Free Medicare Recipients Received Fentanyl Indicated for Cancer Painѻý> These prescriptions could lead to abuse, OIG report warns Mar 02, 2023
<ѻý>Vitamin B3 Doesn't Cut Skin Cancer Risk After Organ Transplantѻý> Randomized study finds no benefit with 12 months of nicotinamide versus placebo Mar 01, 2023
<ѻý>'Alarming' Rise in Colon Cancer Rates Among Younger Peopleѻý> Rate doubled in under-50 age group since 1995, concerning trend toward more advanced disease Mar 01, 2023
<ѻý>How to Make Meaningful Moves Toward Health Equity in Cancer Careѻý> Addressing the three R's: resources, research, and racism Feb 27, 2023
<ѻý>Cancer Drugs That Didn't Work; Another HIV Cure; Kiss of Success With Mistletoeѻý> News, features, and commentary about cancer-related issues Feb 24, 2023
<ѻý>Combo Falters in Papillary Renal Cancer, but Some Promise in MET-Driven Subsetѻý> Over 50% of patients with advanced MET-driven tumors responded to savolitinib plus durvalumab Feb 24, 2023
<ѻý>Gene Tx Shows Sustained Bleeding Control in Severe Hemophilia A at 2 Yearsѻý> Model predicts valoctocogene roxaparvovec could maintain mild hemophilia levels for 5 years Feb 23, 2023
<ѻý>ICI/TKI Combo Maintains Survival Benefit in Advanced RCCѻý> Updated trial data show nivolumab/cabozantinib doublet "is getting better with age" Feb 20, 2023
<ѻý>Pembrolizumab Active in BCG-Unresponsive Papillary High-Risk Bladder Cancerѻý> KEYNOTE-057 trial results suggest DFS benefit for patient population with unmet need Feb 19, 2023
<ѻý>Escalated ADT Falls Short in Men With High-Risk Features After Prostatectomyѻý> But add-on abiraterone and apalutamide may offer some benefits in those with higher PSA Feb 18, 2023
<ѻý>Add-On Olaparib Continues to Show Benefit in First-Line Treatment of mCRPCѻý> Final PROpel analysis also shows trend toward overall survival improvement with PARP inhibitor Feb 17, 2023
<ѻý>Adding Talazoparib to Enzalutamide Boosts PFS in Metastatic Prostate Cancerѻý> Combination achieved a 37% reduction in risk of progression, death versus ARPI alone Feb 17, 2023
<ѻý>Rucaparib Gets a Win in Metastatic Castration-Resistant Prostate Cancerѻý> Benefit in selected patients seen over physician's choice of docetaxel or second-generation ARPI Feb 16, 2023
<ѻý>Targeted Agents Go Head-to-Head for Newly Diagnosed Ph+ ALLѻý> Trial crowns a winner, but how relevant is it amid the changing therapeutic landscape for ALL? Feb 16, 2023
<ѻý>If It Resembles Cancer but Doesn't Act Like Cancer, Is It Cancer?ѻý> Physicians must consider patient perspectives on the Gleason 6 debate Feb 16, 2023
<ѻý>Safe to Omit RT After Lumpectomy in Certain Older Breast Cancer Patientsѻý> Radiotherapy reduced local recurrence, but showed no effect on OS, distant recurrence Feb 15, 2023
<ѻý>The 'Extreme' Story of How Two Game-Changing Cancer Drugs Came to Marketѻý> New book by former Forbes senior editor pulls back the curtain on drug development Feb 13, 2023
<ѻý>FDA Has Concerns on 'Unprecedented' Plan for Dostarlimab in Rectal Cancerѻý> Panel will discuss if single-arm trials and proposed endpoints are adequate to support approval Feb 08, 2023
<ѻý>Biden Pledges to Extend Medicare's Solvency for 'At Least Two Decades'ѻý> Healthcare featured prominently in president's State of the Union address Feb 08, 2023
<ѻý>AI Tool Forecasts Lung Cancer Risk From a Single CT Scanѻý> Experts give high marks to performance of "Sybil" in predicting disease over 6 years Feb 07, 2023
<ѻý>Risk Model-Based Lung Cancer Screening More Cost-Effective Than USPSTF Recsѻý> Risk prediction models more sensitive than age-, smoking history-based methods Feb 07, 2023
<ѻý>Patients' Defensive Thinking May Hinder Colorectal Cancer Screeningѻý> Study explored why people refused at-home stool test Feb 06, 2023
<ѻý>Novel 'Off the Shelf' CAR-T Product Shows Promise in Myelomaѻý> Researchers say safety, efficacy of ALLO-715 comparable to autologous anti-BCMA products Feb 02, 2023